Cubebio is based in Seoul, South Korea. It has raised $46M in total funding. Latest round: Series B.
Cubebio funding overview
Cubebio is based in Seoul, South Korea. Cubebio has raised $46M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2018. The round record for Cubebio runs through 2018; nothing later has been disclosed. Investors on record include Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Cubebio has raised $46M in total disclosed funding across the rounds on record.
Who has invested in Cubebio?
Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital are named among the investors backing Cubebio.
What was the latest Cubebio funding round?
The most recent disclosed round is a Series B, announced in September 2018.
Where is Cubebio based?
Cubebio is based in Seoul, South Korea.
When did Cubebio last raise?
The last disclosed Cubebio round closed in September 2018 at Series B.
Totals shown for Cubebio aggregate every disclosed round on file. To see how that compares, browse the companies in Seoul and the investors behind them below.
